Concepedia

Thierry Buclin

TB

Statistics

Publications

197

Citations

14K

H-Index

62

Active since

1987

Affiliations

University Hospital of Lausanne(Current)

University of Lausanne

University of Geneva

University Hospital of Zurich

University Hospital of Basel

Thierry Buclin is an author at University Hospital of Lausanne specializing in pharmacology, pharmacokinetics, and pharmacy.

ORCID

Publications per year

1987–2025

197

Publications

197

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Andrés Pascual, Thierry Calandra, S. Bolay et al. · Clinical Infectious Diseases · 2007 · 889 citations · Full text

, , +17

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Catia Marzolini, Amalio Telenti, Laurent A. Décosterd et al. · AIDS · 2001 · 836 citations

, , +16

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

Jacques Fellay, Catia Marzolini, E. Rhiannon Meaden et al. · The Lancet · 2002 · 662 citations · Full text

, , +17

Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

Sandrine Ostermann, Chantal Csajka, Thierry Buclin et al. · Clinical Cancer Research · 2004 · 513 citations · Full text

, , +16

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

Margalida Rotger, Sara Colombo, Hansjakob Furrer et al. · Pharmacogenetics and Genomics · 2005 · 412 citations

, , +16

1–5 of 197